For the upcoming earnings call, the "tmdx stock price forecast" could shift if gross margins maintain above 74%, a key profitability metric in medical logistics, potentially driving valuations closer to the $95 psychological level. The consensus estimate for 'Net revenue by OCS product- OCS Liver net revenue' stands at $108.56 million. The estimate indicates a change of +40.9% from the prior-year quarter. Here are three medical technology stocks that are not only outperforming the broader market but are also building compelling bullish setups for the months ahead. The "tmdx stock price forecast" remains in sharp focus after broader biotech and med-tech sector ETFs climbed 3% this month, offering positive correlation signals that may support short-term price gains.